Last quarter (Q4 2022), InhaleRx Limited's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, InhaleRx Limited's net income was $―. See InhaleRx Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ ―	$ 24.80K	$ 167.30K	$ 12.56K	$ 46.60K	$ 345.79K
Cost of Revenue	$ ―	$ ―	$ 115.23K	$ 168.79K	$ ―	$ ―
Gross Profit	$ ―	$ 24.80K	$ 52.07K	$ -156.24K	$ 46.60K	$ 345.79K
Operating Expense	$ ―	$ 1.95M	$ 1.18M	$ 1.06M	$ 2.03M	$ 2.31M
Operating Income	$ ―	$ -1.92M	$ -1.13M	$ -1.22M	$ -1.99M	$ -1.96M
Net Non Operating Interest Income Expense	$ ―	$ 16.13K	$ 334.00	$ 292.00	$ 19.07K	$ 54.71K
Other Income Expense	$ ―	$ 10.92K	$ 14.44K	$ 9.57K	$ -419.56K	$ 155.43K
Pretax Income	$ ―	$ -1.90M	$ -1.11M	$ -1.21M	$ -2.39M	$ -1.75M
Tax Provision	$ ―	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ -26.59K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -1.90M	$ -1.11M	$ -1.21M	$ -2.39M	$ -1.68M
Basic EPS	$ ―	$ -0.01	$ >-0.01	$ -0.01	$ -0.03	$ -0.02
Diluted EPS	$ ―	$ -0.01	$ >-0.01	$ -0.01	$ -0.03	$ -0.02
Basic Average Shares	$ ―	$ 173.05M	$ 167.57M	$ 99.19M	$ 79.93M	$ 77.87M
Diluted Average Shares	$ ―	$ 173.05M	$ 167.57M	$ 99.19M	$ 79.93M	$ 77.87M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income From Continuing And Discontinued Operation	$ ―	$ -1.90M	$ -1.11M	$ -1.21M	$ -2.39M	$ -1.68M
Normalized Income	$ ―	$ -1.90M	$ -1.11M	$ -1.21M	$ -1.88M	$ -1.68M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ ―	$ -1.92M	$ -1.13M	$ -1.22M	$ -1.99M	$ -1.96M
EBITDA	$ ―	$ -1.92M	$ -1.12M	$ -1.22M	$ -1.93M	$ -1.88M

Currency in USD

InhaleRx Limited Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing